Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: A strategy to convert a radio-resistant phenotype into a radiosensitive one

Cancer Letters

Volumn 231, Issue 1, 2006, Pages 102-112

  Avenia, Paola D' ^a   Porrello, Alessandro ^a   Berardo, Marco ^a   Angelo, Marco D' ^a   Soddu, Silvia ^a   Arcangeli, Giorgio ^a   Sacchi, Ada ^a   Orazi, Gabriella D' ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adp53; Brain tumors; Clonogenic survival; Hyper radiosensitivity; Radiotherapy

Indexed keywords

ADENOVIRUS VECTOR; ADVEXIN; PROTEIN P53; RECOMBINANT PROTEIN;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPERSENSITIVITY; LOW ENERGY RADIATION; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY; VIRAL GENE THERAPY; VIRUS RECOMBINANT; X IRRADIATION;

ADENOVIRIDAE; BRAIN NEOPLASMS; CELL SURVIVAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GLIOBLASTOMA; HUMANS; PHENOTYPE; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; X-RAY THERAPY;

ADENOVIRIDAE;

EID: 28844461720     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.033     Document Type: Article

References (45)

1. B.K. Ahmed Rasheed, R.N. Wiltshire, S.H. Bigner, and D.D. Bigner Molecular pathogenesis of malignant gliomas Curr. Opin. Oncol. 11 1999 162 167
2. B.F. Furnari, H.J. Su Huang, and W.K. Cavenee Genetics and malignant progression of human brain tumours Cancer Surveys 25 1999 233 275
3. H.A. Fine, K.B. Dear, J.S. Loeffler, P. Black, and G.P. Canellos Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597
4. D.J. Buchsbaum, D. Raben, M.A. Stockhouse, M.B. Khazaeli, B.E. Rogers, and M.E. Rosenfeld Approaches to enhance cancer radiotherapy employing gene transfer methods Gene Ther. 3 1996 1042 1068
5. J.M. Nigro, S.J. Baker, A.C. Preisinger, J.M. Jessup, R. Hostetter, and K. Cleary Mutations in the p53 gene occur in diverse human tumour types Nature 342 1989 705 708
6. D.W. Ellison, K.C. Gatter, P.V. Steart, D.P. Lane, and R.O. Weller Expression of the p53 protein in a spectrum of astrocytic tumours J. Pathol. 168 1992 383 386
7. R.H. Frankel, W. Bayona, M. Koslow, and E.W. Newcomb P53 mutations in human malignant gliomas: comparison of loss of heterozigosity with mutation frequency Cancer Res. 52 1992 1427 1433
8. D. Sidransky, T. Mikkelsen, K. Schwechheimer, L. Rosenblum, W. Cavanee, and B. Vogelstein Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature 355 1992 846 847
9. J.K. Wu, Z. Ye, and B.T. Darras Frequency of p53 tumor suppressor gene mutations in human primary brain tumors Neurosurg 33 1993 824 830
10. E. Van Meir, T. Kikuchi, M. Tada, H. Li, A.C. Diserens, and B.E. Wojcik Analysis of the p53 gene and its expression in human glioblastoma cells Cancer Res. 54 1994 649 652
11. P. Chen, A. Iavarone, J. Fick, M. Edwards, M. Prados, and M.A. Israel Constitutional p53 mutations associated with brain tumors in young adults Cancer Genet. Cytogenet. 82 1995 106 115
12. F.F. Lang, W.K. Yung, R. Sawaya, and P.J. Tofilon Adenovirus-mediated p53 gene therapy for human gliomas Neurosurgery 45 1999 1093 1104
13. E.G. Van Meir, K. Roemer, A.-C. Diserens, T. Kikuchi, S.A. Rempel, and M. Haas Single cell monotoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells Proc. Natl Acad. Sci. USA 92 1995 1008 1012
14. C. Gomez-Manzano, J. Fueyo, A.P. Kyritsis, P.A. Steck, J.A. Roth, and T.J. McDonnel Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis Cancer Res. 56 1996 694 699
15. H. Koch, M.P. Harris, S.C. Anderson, T. Machemer, W. Hancoch, and S. Sutjipto Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo Int. J. Cancer 76 1996 808 815
16. B. Badie, K.E. Drazan, M.H. Kramar, A. Shaked, and K.L. Black Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats Neurol. Res. 17 1995 209 216
17. S.W. Lowe, H.E. Ruley, T. Jacks, and D.E. Housman p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967
18. L. Geng, S. Walter, E. Melian, and A.T.M. Vaughan Transfection of a vector expressing wild-type p53 into cells of two human glioma cell lines enhances radiation toxicity Radiat. Res. 150 1998 31 37
19. F.F. Lang, W.K. Yung, U. Raju, F. Libunao, N.H.A. Terry, and P. Tofilon Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene J. Neurosurg. 89 1998 125 132
20. W.C. Broaddus, Y. Liu, L.L. Steele, G.T. Gillies, P-S. Lin, and W.G. Loudon Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction J. Neurosurg. 91 1999 997 1004
21. B. Badie, M.H. Kramar, R. Lau, D.A. Boothman, J.S. Economou, and K.L. Black Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors J. Neurooncol. 37 1998 217 222
22. B. Badie, C. Sing Goh, J. Klaver, H. Herweijer, and D.A. Boothman Combined radiation and p53 gene therapy of malignant glioma cells Cancer. Gene Ther. 6 1999 155 162
23. F. Graham, and L. Prevec Manipulation of adenovirus E.J. Murray Methods of Molecular Biology vol. 7 1991 Humana Press Clifton NJ 109 128
24. C. Chen, and H. Okayama High-efficiency transformation of mammalian cells by plasmid DNA Mol. Cell. Biol. 7 1987 2752 2754
25. Y. Barak, T. Juven, R. Haffner, and M. Oren mdm2 expression is induced by wild-type p53 activity Eur. Med. Biol. Org. J. 12 1993 461 468
26. G. D'Orazi, A. Marchetti, M. Crescenzi, S. Coen, A. Sacchi, and S. Soddu Exogenous wt-p53 is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting J. Gene Med. 2 2000 11 12
27. N. Albright Computer programs for the analysis of cellular survival data Radiat. Res. 112 1987 331 340
28. A. Biroccio, D. Del Bufalo, A. Ricca, C. D'Angelo, G. D'Orazi, and A. Sacchi Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule Gene Ther. 6 1999 1064 1072
29. J. Momand, G.P. Zambetti, D. Olson, D. George, and A. Levine The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1992 1237 1245
30. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
31. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
32. J.D. Oliner, K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 1992 80 83
33. E. Hall Radiobiology for the Radiologist 1994 Lippincott Philadelphia, PA
34. S.C. Short, S.A. Mitchell, P. Boulton, M. Woodcock, and M.C. Joiner The response of human glioma cell lines to low-dose radiation exposure Int. J. Radiat. Biol. 75 1999 1341 1348
35. S. Short, C. Mayes, M. Woodcock, H. Johns, and M.C. Joiner Low-dose hypersensitivity in the T98G human glioblastoma cell line In. J. Radiat. Biol. 75 1999 847 855
36. A.S. Lichter, and T.S. Lawrence Recent advance in radiation oncology N. Engl. J. Med. 332 1995 371 379
37. H. Symonds, L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and Van Dyke p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell 78 1994 703 711
38. M.C. Joiner, P. Lambin, E.P. Malaise, T. Robson, J.E. Arrand, and K.A. Skov Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance Mutat. Res. 358 1996 171 183
39. B. Marples, P. Lambin, K.A. Skov, and M.C. Joiner Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells Int. J. Radiat. Biol. 71 1997 721 735
40. B.G. Wouters, and L.D. Skarsgard The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity Radiat. Res. 138 1994 S76 S80
41. B.G. Wouters, A.M. Sy, and L.D. Skarsgard Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity Radiat. Res. 146 1996 399 413
42. P. Lambin, E.P. Malaise, and M.C. Joiner Might intrinsic radioresistance of human tumor cells be induced by radiation Int. J. Radiat. Biol. 69 1996 279 290
43. P.D. Beauchesne, S. Bertrand, R. Branche, S.P. Linke, R. Revel, and J.F. Dore Human malignant glioma cell lines are sensitive to low radiation doses Int. J. Cancer 105 2003 33 40
44. N.K. Sah, A. Munshi, T. Nishikawa, T. Mukhopadyay, J.A. Roth, and R.E. Meyn Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity Mol. Cancer Ther. 11 2003 1223 1231
45. S.L. Scott, J.D. Earle, and P.H. Gumerlock Functional p53 increases prostate cabcer cell survival after exposure to fractionated doses of ionizing radiation Cancer Res. 63 2003 7190 7196